Previous 10 | Next 10 |
Orgenesis to Acquire Tamir Biotechnology's Assets for $19 Million Orgenesis Inc. ( ORGS ) reported that it has signed a deal with Tamir Biotechnology Inc., under which the former will acquire the assets of the latter, including its broad spectrum antiviral platform ranpirnase. The deal is ca...
SCWorx (NASDAQ: WORX ) +171% on order for 2M COVID-19 blood tests. More news on: SCWorx Corp., Can-Fite BioPharma Ltd., Independence Contract Drilling, Inc., Stocks on the move, , Read more ...
April 13, 2020 Palm Beach, FL – April 13, 2020 – The search for a vaccine for the global health crisis is being conducted by companies and countries around the world. Some are taking a cue from older antivirals. Some are tapping tried-and-true technologies, and other...
The patient was treated with PLX cell therapy at Holy Name Medical Center in New Jersey. Prior to the treatment, the patient was critically ill with respiratory failure and was under medical ventilation in an ICU for three weeks. More news on: Pluristem Therapeutics Inc., Healthcare ...
Cleared by FDA to proceed with the treatment in U.S. under Coronavirus Treatment Acceleration Program (CTAP) Pluristem’s main focus: multinational clinical trial of PLX cells for treatment of complications associated with COVID-19 ...
Gainers: Independence Contract Drilling (NYSE: ICD ) +204% . More news on: Independence Contract Drilling, Inc., Pluristem Therapeutics Inc., Nautilus, Inc., Stocks on the move, , Read more ...
April 8, 2020 Palm Beach, FL – April 8, 2020 – The search for vaccines and treatments for the global health crises is now focusing on medicines that are presently approved for other ailments. A recent article in the LA Times discussed this issue saying that when ...
Gainers: Sasol (NYSE: SSL ) +88% . More news on: Sasol Limited, Western Asset Mortgage Capital Corporation, Caleres, Inc., Stocks on the move, , Read more ...
Sasol (NYSE: SSL ) +47% . More news on: Sasol Limited, Cherry Hill Mortgage Investment Corporation, Can-Fite BioPharma Ltd., Stocks on the move, , Read more ...
Thinly traded nano cap Pluristem Therapeutics (NASDAQ: PSTI ) spikes 55% premarket on increased volume in reaction to preliminary data on the use of its PLX cells in severely ill COVID-19 patients in Israel. More news on: Pluristem Therapeutics Inc., Healthcare stocks news, S...
News, Short Squeeze, Breakout and More Instantly...
Pluristem Therapeutics Inc. Company Name:
PSTI Stock Symbol:
NASDAQ Market:
Pluristem Therapeutics Inc. Website:
HAIFA, Israel, July 25, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”) (formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today issued an update to its shareholders from its Chief Executi...
As of July 26 , 2022 , Pluri ’s stock will trade under the symbol PLUR The new name reflects the Company ’s strategy to leverage its innovative 3D cell-based technology to a range of fields, developing cel...
The Company will host an analyst and investor call to discuss the phase III muscle regeneration following hip fracture surgery topline results on July 14 at 9:00 a.m. ET; for registration: https://pluristem.zoom.us/webinar/register/WN_kp_CwQQtR-aFtjAXrdiJpA HAIFA, Israel, Ju...